On December 12, Ark Innovation (ARKK, Financial), Cathie Wood’s company, revealed its trading portfolio, showing how assets are moving from one Ark ETF to the next. The ARKK ETF sold 51,335 shares of Tesla Inc. (TSLA, Financial), the largest trade of the day, with a total of $21.81 million. This transaction means that ARK is regaining its position as a leader in the electric vehicle market.
Accordingly, ARK became optimistic about Tempus’s (TEM, Money) outlook, adding 424,522 shares to its ARKK and ARKG ETFs for a total of $18,000. This purchase further strengthened ARK’s position in the market for artificial intelligence.
In another noteworthy move, ARKQ ETF sold 205,897 shares of Rocket Lab USA (RKLB, Financial). Funds were also transferred to purchase 154,873 shares of Symbotic (SYM, Financial) for $445 million ($4.81 million), or $4.81 million. ARK showed interest in robotics and automation components, as this shows.
Other transactions included the sale of Adaptive Biotechnologies Corp. (ADPT, Financial): On Friday, Veracyte Inc. (VCYT, Financial) sold 31,181 shares worth $1.36 million, ADPT sold 20,353 shares worth $129,852, and Veeva Systems Inc. (VEEV , Financial) sold 4,660 shares valued at $1.09 million. Senti Biosciences Inc. (SNTI, Financial): A small correction of 163 shares was seen at SNTI $893. However, investors are closely following the movements of ARK, trading on the knowledge of its initial value: Many believe that ARK shows confidence in AI innovation, and the sale of Tesla may be a profit-taking or portfolio recomposition.
This article first appeared on GuruFocus.